38 related articles for article (PubMed ID: 30223007)
1. A novel protein isoform of the RON tyrosine kinase receptor transforms human pancreatic duct epithelial cells.
Chakedis J; French R; Babicky M; Jaquish D; Howard H; Mose E; Lam R; Holman P; Miyamoto J; Walterscheid Z; Lowy AM
Oncogene; 2016 Jun; 35(25):3249-59. PubMed ID: 26477314
[TBL] [Abstract][Full Text] [Related]
2. Targeting isoforms of RON kinase (MST1R) drives antitumor efficacy.
Kim J; Koh DI; Lee M; Park YS; Hong SW; Shin JS; Lee MS; Kim MH; Lee JH; Jeong J; Bae S; Hong JK; Jeong HR; Ryu YS; Kim SM; Choi M; Kim H; Ryu H; Hur SC; Park J; Hur DY; Jin DH
Cell Death Differ; 2023 Dec; 30(12):2491-2507. PubMed ID: 37926711
[TBL] [Abstract][Full Text] [Related]
3. Plasma membrane proteoglycans syndecan-2 and syndecan-4 engage with EGFR and RON kinase to sustain carcinoma cell cycle progression.
Beauvais DM; Nelson SE; Adams KM; Stueven NA; Jung O; Rapraeger AC
J Biol Chem; 2022 Jun; 298(6):102029. PubMed ID: 35569509
[TBL] [Abstract][Full Text] [Related]
4. Predicting the Structural Impact of Human Alternative Splicing.
Song Y; Zhang C; Omenn GS; O'Meara MJ; Welch JD
bioRxiv; 2023 Dec; ():. PubMed ID: 38187531
[TBL] [Abstract][Full Text] [Related]
5. The HNRNPA2B1-MST1R-Akt axis contributes to epithelial-to-mesenchymal transition in head and neck cancer.
Gupta A; Yadav S; Pt A; Mishra J; Samaiya A; Panday RK; Shukla S
Lab Invest; 2020 Dec; 100(12):1589-1601. PubMed ID: 32669614
[TBL] [Abstract][Full Text] [Related]
6. Targeting RON receptor tyrosine kinase for treatment of advanced solid cancers: antibody-drug conjugates as lead drug candidates for clinical trials.
Yao HP; Suthe SR; Tong XM; Wang MH
Ther Adv Med Oncol; 2020; 12():1758835920920069. PubMed ID: 32426050
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive analysis of DNA methylation and gene expression profiles in cholangiocarcinoma.
Zhang C; Zhang B; Meng D; Ge C
Cancer Cell Int; 2019; 19():352. PubMed ID: 31889904
[TBL] [Abstract][Full Text] [Related]
8. Multiple variants of the RON receptor tyrosine kinase: biochemical properties, tumorigenic activities, and potential drug targets.
Lu Y; Yao HP; Wang MH
Cancer Lett; 2007 Nov; 257(2):157-64. PubMed ID: 17889431
[TBL] [Abstract][Full Text] [Related]
9. RON, a tyrosine kinase receptor involved in tumor progression and metastasis.
Camp ER; Liu W; Fan F; Yang A; Somcio R; Ellis LM
Ann Surg Oncol; 2005 Apr; 12(4):273-81. PubMed ID: 15827676
[TBL] [Abstract][Full Text] [Related]
10. Identification of the splice variants of Recepteur d'Origine nantais (RON) in lung cancer cell lines.
Krishnaswamy S; Bukhari I; Mohammed AK; Amer OE; Tripathi G; Alokail MS; Al-Daghri NM
Gene; 2018 Dec; 679():335-340. PubMed ID: 30223007
[TBL] [Abstract][Full Text] [Related]
11. Splice variants of the extracellular region of RON receptor tyrosine kinase in lung cancer cell lines identified by PCR and sequencing.
Krishnaswamy S; Mohammed AK; Tripathi G; Alokail MS; Al-Daghri NM
BMC Cancer; 2017 Nov; 17(1):738. PubMed ID: 29121914
[TBL] [Abstract][Full Text] [Related]
12. Novel splicing variants of recepteur d'origine nantais (RON) tyrosine kinase involving exons 15-19 in lung cancer.
Krishnaswamy S; Mohammed AK; Amer OE; Tripathi G; Alokail MS; Al-Daghri NM
Lung Cancer; 2016 Feb; 92():41-6. PubMed ID: 26775595
[TBL] [Abstract][Full Text] [Related]
13. Recepteur d'Origine nantais (RON) tyrosine kinase splicing variants lacking exons 18 and 19 occur ubiquitously in lung cancer.
Krishnaswamy S; Mohammed AK; Amer OE; Tripathi G; Alokail MS; Al-Daghri NM
Int J Clin Exp Med; 2015; 8(11):20778-86. PubMed ID: 26885001
[TBL] [Abstract][Full Text] [Related]
14. RON receptor tyrosine kinase in human gliomas: expression, function, and identification of a novel soluble splice variant.
Eckerich C; Schulte A; Martens T; Zapf S; Westphal M; Lamszus K
J Neurochem; 2009 May; 109(4):969-80. PubMed ID: 19519771
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
